IDH2 and central nervous system cancer: The network presented in Figure 7 provides insights into the molecular mechanisms underlying glioma progression, particularly alterations in chromatin remodeling (ATRX), neurodevelopmental transcriptional regulation (OLIG2), DNA repair (MGMT), and metabolic reprogramming (IDH2).